Prematurity; Extreme Clinical Trial
Official title:
Utilization of Near-Infrared Spectroscopy Technology to Determine Normative Cerebral Regional Oxygen Saturation in a Preterm Population Born at Altitude
NCT number | NCT04639583 |
Other study ID # | 20-382 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 1, 2021 |
Est. completion date | June 30, 2023 |
Verified date | May 2024 |
Source | University of New Mexico |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Near-infrared spectroscopy (NIRS), is a technology that can provide continuous, non-invasive monitoring of oxygenation in tissue. The objective of this study is to obtain the cerebral regional oxygen saturation (cRSO2) in a preterm population that is born at altitude to determine if the range of "normal" values is different than those obtained at sea level.
Status | Completed |
Enrollment | 21 |
Est. completion date | June 30, 2023 |
Est. primary completion date | June 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 0 Hours to 24 Hours |
Eligibility | Inclusion Criteria: - Infant must be <32 weeks' gestational age at time of delivery. - Consenting mother/guardian of the infant must speak English. Other languages are not being included due to the need of a translator being brought into the unit, which adds risk to the vulnerable population. Additionally, as the time to consent is a narrow window, adding the complexity of getting a translator may delay the ability to get consent and thus make it more difficult to enroll patients. - Infants that require blood transfusions during the monitoring time may be included. Exclusion Criteria: - Any known cardiac anomaly or other anomaly which may impair perfusion and blood flow. - Infant born after placental abruption or concern for extreme blood loss immediately after birth. - Unable to consent the mother/guardian due to maternal health issues after delivering (eg requiring intubation or sedation after the delivery). - Mothers/guardians that are prisoners, as the study team would like to have continuing communication with the mother during the study period as needed. - Mothers/guardians that are <18 years of age will not be approached for consent. - Any mother/guardian that is not able to consent due to having a legal representative will not be approached for consent in this study. - Any infant that is planned to be placed for adoption - Infant is greater than 24 hours of age at time of consent. |
Country | Name | City | State |
---|---|---|---|
United States | University of New Mexico | Albuquerque | New Mexico |
Lead Sponsor | Collaborator |
---|---|
University of New Mexico |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cerebral Regional Oxygen Saturation (cRSO2) | Measure cRSO2 for the first 96 hours of life in infants born preterm. | first 96 hours of life | |
Secondary | Incidence of Major Complications of Prematurity | Additional items recorded to determine if there is any correlation with the cRSO2 values, including death, intraventricular hemorrhage, necrotizing enterocolitis, sepsis, duration of supplemental oxygen required, time to taking full volume feeds via nippling, and hospital length of stay. | From birth until the end of the birth hospitalization, which would be discharge home or death, whichever occurs first. Estimated time is up to 6 months of age. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03641209 -
Extremely Low Gestatonal Age Infants' Paracetamol Study
|
Phase 1/Phase 2 | |
Recruiting |
NCT04114435 -
Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants
|
||
Recruiting |
NCT04294368 -
Targeted Fortification of Donor Breast Milk in Preterm Infants
|
N/A | |
Completed |
NCT03504215 -
Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health.
|
N/A | |
Recruiting |
NCT05615311 -
Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm
|
Phase 1/Phase 2 | |
Recruiting |
NCT04735315 -
Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study
|
||
Completed |
NCT05684419 -
Preterm Infants Born to Homeless Mothers.
|
||
Recruiting |
NCT04270240 -
A NEW SCORING SYSTEM FOR PREDICTION OF PDA
|
||
Completed |
NCT04535375 -
Sonographic QUantification of Venous Circulation In the Preterm Brain
|
N/A | |
Recruiting |
NCT05280340 -
Anakinra for Preterm Infants Pilot
|
Phase 1/Phase 2 | |
Recruiting |
NCT05827250 -
Vibroacoustic Study of Lung Development in Newborn Infants
|
||
Recruiting |
NCT05824377 -
To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation.
|
N/A | |
Completed |
NCT03635944 -
Nutritional Care and Head Growth in Preterm Infants
|
||
Completed |
NCT03261609 -
Risk of Chronic Diseases in Young Adults Born Preterm: Relationship With Inflammation and Oxidative Stress Biomarkers.
|
||
Active, not recruiting |
NCT04325308 -
Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk
|
N/A | |
Active, not recruiting |
NCT04545866 -
The Budesonide in Babies (BiB) Trial
|
Phase 3 |